Breast cancer in young women: clinical decision-making in the face of uncertainty.
Ruddy
Kathryn J
KJ
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Partridge
Ann H
AH
D000328:Adult; D000367:Age Factors; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D003657:Decision Making; D005260:Female; D005298:Fertility; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D010053:Ovary / Q000187:drug effects; D017697:Premenopause; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D019389:Cytochrome P-450 CYP2D6; D018719:Erb-b2 Receptor Tyrosine Kinases; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen